Envoy Medical COCH Increase Decrease In Derivative Liabilities
Increase Decrease In Derivative Liabilities at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDerivativeLiabilities.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's increase decrease in derivative liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Envoy Medical's increase decrease in derivative liabilities?
- Envoy Medical (COCH) reported increase decrease in derivative liabilities of -$78K in Q1 2026.
- How has Envoy Medical's increase decrease in derivative liabilities changed year-over-year?
- Envoy Medical's increase decrease in derivative liabilities decreased by 358.8% year-over-year, from -$17K to -$78K.
- What does increase decrease in derivative liabilities mean?
- Reflects the net change in the fair value of financial instruments, such as warrants or options, that are classified as liabilities. This metric captures the impact of market volatility and changes in the company's valuation on its outstanding financial commitments.